Pharmaspectra Group Limited Partners with IBM Watson Health to Help Life Sciences Companies with Stakeholder Management
Pharmaspectra announced it has entered into a partnership with IBM Watson Health.
READ MORE
Complimentary Covid-19 Database
Pharmaspectra captures all science as it is disseminated the world over and we are committed to supporting our customers in the fight against the COVID-19 pandemic. With this purpose in mind, we have built a database specifically for coronaviruses, that is tracking information containing all publications and meeting proceedings in real time, as soon as the science becomes available.
READ MORE
PHARMASPECTRA AND DOCTOR EVIDENCE TEAM UP TO COMBINE LEADING CONGRESS DATA WITH LEADING AI SEARCH TECHNOLOGY
Doctor Evidence and Pharmaspectra have formed an alliance where Pharmaspectra’s datahub, Insightmeme® global Congress data captured from monitoring over 18,000 meetings per year will be offered in Doctor Evidence’s powerful search platform, DOC Search®.
READ MORE
Pharmaspectra’s Global Meetings Coverage
With medical literature, it’s not only important to access the information from the tens of thousands of global sources, but to understand the historical context as well.
READ MORE
PHARMASPECTRA ANNOUNCES INVESTMENT IN ITS FUTURE GROWTH PLAN
Pharmaspectra receives funding from private equity firm, Inflexion.
READ MORE
Identifying Predatory Journals
The rise of these predatory journals has largely been driven by the “publish or perish” dictum predominant in academia, where careers, promotions, and funding can depend on publishing research. To identify these problematic publications, look for these hallmarks
READ MORE
The Role of Medical Affairs in Healthcare
As healthcare has evolved, the ecosystem has become more complex. Today medical affairs is in a position to help facilitate the communication
READ MORE
When Real-World Evidence and Randomized Clinical Trials Disagree
The findings of real-world evidence studies sometimes contradicts the results of randomized clinical trials. This raises the question of how to reconcile the two.
READ MORE
Rethinking Journal Submissions
Where to Publish Drug Trial Results? Traditional Journal Rankings Fail to Deliver their Promised Impact
READ MORE
3 Flaws in the Journal Impact Factor
The JIF has come under growing criticism for its various shortcomings. These include its ineffectiveness as a tool for predicting an article's impact, the opaque methods used to calculate it, and its potential for misuse.
READ MORE
